Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-1 beta inhibitor PubMed DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Pericarditis 4 D010493 ClinicalTrials
Gout 3 D006073 ClinicalTrials
Familial Mediterranean Fever 2 D010505 ClinicalTrials
Hepatitis, Alcoholic 2 D006519 ClinicalTrials
Arthritis, Juvenile 2 D001171 ClinicalTrials
Diabetes Mellitus, Type 1 1 D003922 ClinicalTrials
Scleroderma, Diffuse 1 D045743 ClinicalTrials
Hearing Loss 0 D034381 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
18.84
Gastrointestinal disorders
14.49
Infections and infestations
9.18
Injury, poisoning and procedural complications
7.73
Respiratory, thoracic and mediastinal disorders
7.25
Musculoskeletal and connective tissue disorders
6.28
Skin and subcutaneous tissue disorders
6.28
Nervous system disorders
5.31
Surgical and medical procedures
5.31
Cardiac disorders
2.42
Investigations
2.42
Vascular disorders
2.42

Cross References

Resources Reference
CAS NUMBER 501081-76-1
ChEMBL CHEMBL1201830
FDA SRS 8K80YB5GMG
Guide to Pharmacology 6790